Advertisement

Topics

Latest Gastroenterology NewsRSS

14:31 EDT 30th March 2017 | BioPortfolio

Raleigh-Durham Walks to End Pancreatic Cancer at PurpleStride

Funds raised at PurpleStride support vital research and clinical initiatives of the Pancreatic Cancer Action Network The Pancreatic Cancer Action Network’s Raleigh-Durham Affiliate invites the community to join PurpleStride

The U.S. Burden of Neurological Disease is Nearly $800 Billion/Year According to New American Neurological Association Study

MT. LAUREL, N.J., March 30, 2017 /PRNewswire/ -- The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology. The research shows the price tag of this serious, annual financial burden for the natio...

On Opening Day, Nearly Half of Major League Stadiums Will Be Tobacco-Free - MLB Cities Need to Finish the Job for Our Kids

WASHINGTON, March 30, 2017 /PRNewswire-USNewswire/ -- The following is a statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids: When the 2017 Major League Baseball season opens in just a few days, more ballparks and games will be tobacco-free than ever before – and that's a terrific example for millions of young fans. Nearly half the Major League stadiums (14 of 30) w...

PerkinElmer Shares Future Trends to Improve Testing Systems

LabRoots will host the webinar April 20, where attendees will gain a better understanding of cancer heterogeneity and drug resistance. Yorba Linda, Ca (PRWEB) March 30, 2017 With increasing breadth and depth of genomics studies across a range of cancers, it is now apparent that there exists significant inter and intra tumoural heterogeneity, with complex genotypes comprising of multiple co-existi...

Anthony Anderson, LeAnn Rimes, Felicity Huffman And Martin Short Sing In New PSAs From Stand Up To Cancer And Rally Health

LOS ANGELES and SAN FRANCISCO, March 30, 2017 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and Rally Health, Inc. launched today a series of video public service announcements (PSAs) featuring actor and comedian Anthony Anderson, singer LeAnn Rimes, actress Felicity Huffman and actor and comedian Martin Short. The digital and broadcast public awareness campaign is part of SU...

Former Pfizer R&D President Joins Frequency Therapeutics’ SAB

Frequency Therapeutics, a company developing a pipeline of drugs by activating progenitor cells within the body, today announced the appointment of John LaMattina, Ph.D. as a Senior Advisor to the CEO, and a member of the Scientific Advisory Board. “As a highly-regarded industry veteran, John brings us a wealth of knowledge and expertise,...

Global Alpha Emitters Market by Type and Application Industry Analysis, Size, Share, Growth Trends and Forecasts 2016 2021 [Updated: 01122016] Prices from USD $4255

The global market for alpha emitters is currently estimated to be valued at $107 million for the year 2015 and is poised to reach $283 million by the end of 2020. The CAGR during this period of forecast is 21.5%.Alpha emitter radionuclide is considered to be a new approach to tackle cancer and related issues. Alpha emitter provides many advantages when compared to beta emitters and photon therapy,...

Panacea Pharmaceuticals, Inc. Presents Data on Targeted Killing of Leukemia Cells By Its Radiolabeled Monoclonal Antibody to the Cancer Biomarker HAAH

GAITHERSBURG, Md., March 30, 2017 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. presents a paper regarding targeted killing of leukemia cells by a radiolabeled monoclonal antibody at the annual American Association for Cancer Research (AACR) meeting in Washington DC held April 1-5, 2017. The paper is titled: "Radioimmunotherapy for Acute Myeloid Leukemia Targeting Human Aspartyl (Asparagi...

Panacea Pharmaceuticals, Inc. Presents Data That Its Cancer Biomarker HAAH is Readily Detectable in Serum Exosomes

GAITHERSBURG, Md., March 30, 2017 /PRNewswire/ -- Panacea Pharmaceuticals, Inc. presents a paper regarding detection of the cancer biomarker HAAH at the annual American Association for Cancer Research (AACR) meeting in Washington DC held April 1-5, 2017. The paper is titled: "Improved Detection of Cancer Specific Serum Exosomal Aspartyl (Asparaginyl) beta Hydroxylase (HAAH)" The paper demo...

On the horizon: Genes pointing to potential Parkinson’s disease therapies

First-in-Human Genolimzumab Phase 1 Study Initiated to Assess Safety and Preliminary Efficacy in Patients with Select Advanced Solid Tumors

CBT Pharmaceuticals (Australia) Pty Ltd Established CBT Pharmaceuticals, Inc. (CBT), a life sciences company focused on developing innovative oncology therapeutics, announced today that the first patient has been enrolled in the genolimzumab (CBT-501) Phase 1 study, the company’s first clinical trial. The trial is designed to evaluate the safety, tol...

Aura Biosciences Announces Initiation of Phase 1b Clinical Trial and Receipt of FDA Fast Track Designation for AU-011 for the Treatment of Primary Ocular Melanoma

First patient dosed with light-activated AU-011 at Wills Eye Hospital in Philadelphia Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells using viral nanoparticle conjugates, announced today that it has enrolled and dosed the first patient in its Phase 1b clinical trial of light-a...

Seven Bridges CEO Brandi Davis-Dusenbery Joins NCI’s Cancer Genomics Cloud Program at AACR Annual Meeting

Seven Bridges will also Present Two Poster Sessions at the Event, Focused on Petabyte-Scale Cancer Genomics Research Seven Bridges, the biomedical data analysis company, today announced that CEO Brandi Davis-Dusenbery will take part in a

Fred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 20032017] Prices from USD $250

SummaryFred Hutchinson Cancer Research Center Fred Hutchinson is a nonprofit organization that research on the prevention, diagnose and treatment of cancer, HIV/AIDS and other life threatening diseases. The organization conducts research to improve prevention and treatment of cancer and related diseases. It conducts research on various diseases such as cervical cancer, colorectal cancer, crohn's d...

Lonza Expands Airway Disease Portfolio with Addition of IPF Airway Cells

Lonza now offers cryopreserved lung fibroblasts isolated from donors diagnosed with Idiopathic Pulmonary Fibrosis (IPF) for use in research into this potentially fatal condition. Normal lung fibroblasts and small airway epithelial cells – from both smokers and non-smokers – are also available, offering a complete solution to facilitate IPF and other airway research. Lonza’s abili...

Oral Cancer Awareness Survey Reveals 81 Percent of U.S. Adults Want to Be Screened for Oral Cancer During Routine Dental Check-ups; Only 29 Percent Actually Are

FORT LAUDERDALE, Fla., March 30, 2017 /PRNewswire/ -- According to a national survey released today, the majority (62 percent) of adults in the U.S. know very little, or nothing at all, about oral cancer (including cancer of the oral cavity, tongue, larynx and pharynx), and only 29 percent report being screened for oral cancer at their last dental checkup. The survey was conducted by Vig...

Samus Therapeutics Announces Launch of Expanded Clinical Development Programs for Novel Anti-Epichaperome Small Molecules to Diagnose and Treat Cancer and Neurodegenerative Disease

BOSTON, March 30, 2017 /PRNewswire/ -- Samus Therapeutics, Inc. ("Samus" or the "Company"), a privately held Boston-based biopharmaceutical company developing novel therapeutics and diagnostics targeting the epichaperome, today announced the launch of an expanded development program for the Company's lead anti-epichaperome candidates, including PU-H71 in various cancers and PU-AD in neurodegenerat...

Antitumor Immunity Triggered by DNAtrix Armed Viruses to be Presented at the 2017 Annual Meeting of the American Association for Cancer Research

HOUSTON, March 30, 2017 /PRNewswire/ -- DNAtrix, a clinical stage biotechnology company developing virus-driven immunotherapies for cancer, today announced that results from four studies based on the DNAtrix armed virus platform, co-authored by Juan Fueyo, MD, a professor at MD Anderson Cancer Center Department of Neuro-Oncology, will be presented at the upcoming 2017 Annual Meeting of the Am...

Debbie's Dream Foundation: Curing Stomach Cancer Hosts 8th Annual Dream Makers Gala

FORT LAUDERDALE, Fla., March 30, 2017 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF) is excited to host its 8th annual Dream Makers Gala on Saturday, April 29, 2017 at The Diplomat Beach Resort in Hollywood, Florida beginning at 7 p.m. The evening will feature a cocktail hour and a terrific silent auction followed by a delicious dinner, award presentation, a live aucti...

Tango Launched with $55M to Exploit Sequencing and CRISPR Target Discovery

Third Rock Ventures has launched a new c ancer drug discovery and development company, Tango Therapeutics, with a $55 million Series A investment. The new firm, based in Cambridge, MA, is exploiting a platform that combines sequencing and CRISPR-based screening to identify new cancer-specific targets and drug candidates. Tango will have three primary areas of focus: addressing tumor suppressor...

Crown Bioscience to Showcase Scientific Expertise and Data Digital Platform at American Association for Cancer Research

SANTA CLARA, Calif., March 30, 2016 /PRNewswire/ -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, will showcase scientific expertise at the American Association of Cancer Research (AACR) 2017 Annual Me...

Vortex Biosciences Presents Studies at AACR That Demonstrate Use of the VTX-1 System for Isolating and Analyzing Circulating Tumor Cells for Cancer Research

In Collaboration with Stanford University School of Medicine and UCLA, Studies Demonstrate Use of Circulating Tumor Cells in Colorectal, Non-Small Cell Lung and Breast Cancer Research MENLO PARK, CA (PRWEB) March 30, 2017 Vortex Biosciences, provider of circulating tumor cell (CTC) capture systems, will present four posters at the American Association for Cancer Research (AACR) Annual Meeting 201...

Sky Ridge Joins Forces With Hundreds of Local and National Organizations to Increase Colorectal Cancer Screening Rates

LONE TREE, Colo., March 30, 2017 /PRNewswire/ -- Colorectal cancer screening saves lives. Sky Ridge Medical Center took the pledge to help increase colorectal cancer screening rates by supporting the 80% by 2018 initiative led by the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC) and the National Colorectal Cancer Roundtable (a coalition co-founded by ACS and C...

Targeted Agent Rova-T Active in Small-Cell Lung Cancer

This video discusses the phase I trial of rovalpituzumab (Rova-T) for the treatment of patients with small-cell lung cancer.

ADAO Applauds the U.S. Senate for Unanimously Passing the Thirteenth Annual Resolution Designating April 1-7 “National Asbestos Awareness Week”

With Mesothelioma Deaths on the Rise and Impending EPA Risk Evaluation, the 2017 Resolution Takes on New Significance The Asbestos Disease Awareness Organization (ADAO), the largest nonprofit in the U.S. dedicated to preventing asbestos exposure, eliminating asbestos-related diseases, and protecting asbestos victims’ civil rights; today pra...

Quick Search
Advertisement
 

review and buy Gastroenterology market research data and corporate reports here